Emanuela Tassoni

Title: Emanuela Tassoni: Innovator in Pharmaceutical Chemistry

Introduction

Emanuela Tassoni is a notable inventor based in Pomezia, Italy. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. Her work focuses on innovative solutions for medical treatments, particularly in diabetes management.

Latest Patents

Among her latest patents is the invention of a new crystalline form of R-4-trimethylammonium-3-(tetradecylcarbamoyl)-amino butyrate, also known as crystalline Form I of ST 1326 or teglicar. This invention includes a detailed process for its preparation and pharmaceutical compositions containing the compound. Another significant patent involves the use of derivatives of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids. These derivatives are described for their potential in preparing medicines aimed at the prophylaxis and treatment of diabetes, particularly type 2 diabetes, along with its complications and various forms of insulin resistance.

Career Highlights

Emanuela works at Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she continues to develop her innovative ideas. Her research has led to advancements in pharmaceutical formulations that can significantly impact patient care.

Collaborations

Emanuela collaborates with esteemed colleagues such as Fabio Giannessi and Maria Ornella Tinti, contributing to a dynamic research environment that fosters innovation.

Conclusion

Emanuela Tassoni's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents and ongoing research are paving the way for new treatments that can improve the quality of life for individuals with diabetes.